Enterocolitis, Necrotizing: Clinical Trials

17 trials for Enterocolitis, Necrotizing, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 4 unknown, 2 active not recruiting, 1 not yet recruiting. 17 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 317Completed 9, Unknown 4, Active not recruiting 2, Not yet recruiting 1, Terminated 1
Phase 23Active not recruiting 1, Completed 1, Unknown 1

Follow Enterocolitis, Necrotizing: new trials by email Literature Review of Enterocolitis, Necrotizing trials Research Report on Enterocolitis, Necrotizing

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multi-strain Probiotics to Prevent Necrotizing Enterocolitis in Very Preterm Infants
Multi-strain probiotics - Necrotizing Enterocolitis (NEC)
Phase 3Not yet recruitingUniversity of Calgary21702025-06-012025-02-05
Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis
Pentoxifylline, Probiotic Formula - Necrotizing Enterocolitis
Phase 3CompletedTanta University752022-06-302024-05-20
Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion
Continuous amnioinfusion with Amnion Flush Solution through the intraamniotic catheter - Bronchopulmonary Dysplasia, Necrotizing Enterocolitis
Phase 3UnknownMartin-Luther-Universität Halle-Wittenberg682021-01-012021-01-12
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
IBP-9414, Placebo - Necrotizing Enterocolitis
Phase 3Active not recruitingInfant Bacterial Therapeutics21582019-07-042024-04-12
Human Milk Fortification in Extremely Preterm Infants
H2MF, Bovine milk-based fortifier - Necrotizing Enterocolitis, Sepsis
Phase 2 / Phase 3Active not recruitingThomas Abrahamsson, MD, PhD2292019-02-012024-07-23
Bovine Lactoferrin and Neonatal Survival in Low Birth Weight Babies.
bLF (Bovine lactoferrin), Glucon-D 99.4% (Placebo) - Neonatal Sepsis, Necrotizing Enterocolitis
Phase 3UnknownAga Khan University3002018-05-012020-04-09
The Efficacy of Symbiotic on Cytokines
distilled water, symbiotic - Necrotising Enterocolitis
Phase 3CompletedZeynep Kamil Maternity and Pediatric Research and Training Hospital702013-07-012014-08-08
Role of Probiotics for Prevention of NEC in Preterm VLBW Infants
Probiotics, Breast milk - Necrotizing Enterocolitis
Phase 3CompletedSylhet M.A.G.Osmani Medical College602012-07-012016-01-08
Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants
Lactobacillus reuteri, Placebo - Necrotizing Enterocolitis, Very Low Birth Weight Infants
Phase 3CompletedZekai Tahir Burak Women's Health Research and Education Hospital4002012-02-012013-05-13
Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature Infants
Probiotic, Placebo - Necrotizing Enterocolitis
Phase 3CompletedUniversity of Stellenbosch1842011-07-012013-07-22
Effect of L-arginine and Glutamine on Preterm
Glutamine, l-arginine - NEC, Sepsis
Phase 2 / Phase 3CompletedAin Shams University752011-05-012014-04-15
Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants
Saccharomyces boulardii, Placebo - Necrotizing Enterocolitis, Very Low Birth Weight Infants
Phase 3UnknownZekai Tahir Burak Women's Health Research and Education Hospital2202011-02-012011-08-08
Prophylactic Probiotics in Premature Infants
Lactobacillus reuteri, Placebo - Death, Nosocomial Infection
Phase 3TerminatedColombian Neonatal Research Network7512008-08-012011-06-22
Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis
Vitamin A - Sepsis, Necrotizing Enterocolitis
Phase 3CompletedJohns Hopkins University4242006-12-012013-09-25
Cysteine Supplementation in Critically Ill Neonates
Parenteral cysteine-HCl supplementation, Placebo - added premasol - Sepsis, Bronchopulmonary Dysplasia
Phase 2 / Phase 3UnknownUniversity of California, Los Angeles1082006-09-012010-02-26
Effect of Oral Probiotic Supplementation on The Rate of Hospital Acquired Infection and Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants
probiotics - Nosocomial Infection, Necrotizing Enterocolitis
Phase 3CompletedKing Chulalongkorn Memorial Hospital1602005-01-012011-04-22
Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)
indomethacin, Indomethacin, Placebo - Infant, Very Low Birth Weight, Infant, Premature
Phase 3CompletedNICHD Neonatal Research Network12021993-11-012015-06-08

Narrower conditions

Sepsis (4)  ·  Bronchopulmonary Dysplasia (2)  ·  Cross Infection (2)  ·  Premature Birth (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Death (1)  ·  Ductus Arteriosus, Patent (1)  ·  Intracranial Hemorrhages (1)  ·  Meningitis (1)  ·  Neonatal Sepsis (1)  ·  Pneumonia (1)  ·  Preterm Premature Rupture of the Membranes (1)  ·  Retinopathy of Prematurity (1)  ·  Systemic Inflammatory Response Syndrome (1)

Broader conditions

Digestive System Diseases (17)  ·  Enterocolitis (17)  ·  Gastroenteritis (17)  ·  Gastrointestinal Diseases (17)  ·  Intestinal Diseases (17)  ·  Infections (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Inflammation (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Systemic Inflammatory Response Syndrome (4)  ·  Infant, Newborn, Diseases (3)  ·  Lung Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Cardiovascular Diseases (2)

Interventions

Probiotics (3)  ·  Arginine (1)  ·  Glutamine (1)  ·  Indomethacin (1)  ·  Milk, Human (1)  ·  Pentoxifylline (1)  ·  Vitamin A (1)  ·  amino-acid, glucose, and electrolyte solution (1)

Sponsors

Zekai Tahir Burak Women's Health Research and Education Hospital (2)  ·  Aga Khan University (1)  ·  Ain Shams University (1)  ·  Colombian Neonatal Research Network (1)  ·  Infant Bacterial Therapeutics (1)  ·  Johns Hopkins University (1)  ·  King Chulalongkorn Memorial Hospital (1)  ·  Martin-Luther-Universität Halle-Wittenberg (1)  ·  NICHD Neonatal Research Network (1)  ·  Sylhet M.A.G.Osmani Medical College (1)  ·  Tanta University (1)  ·  Thomas Abrahamsson, MD, PhD (1)  ·  University of Calgary (1)  ·  University of California, Los Angeles (1)  ·  University of Stellenbosch (1)

Countries

Turkey (Türkiye) (3)  ·  United States (3)  ·  Egypt (2)  ·  Bangladesh (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Colombia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Pakistan (1)  ·  Poland (1)  ·  Romania (1)  ·  Serbia (1)

Top investigators

Almas Aamir, MSC (1)  ·  Avroy A. Fanaroff, MD (1)  ·  Barbara J. Stoll, MD (1)  ·  Barbara Schmidt, MD (1)  ·  Charles R. Bauer, MD (1)  ·  Christian L Coles, PhD (1)  ·  David K. Stevenson, MD (1)  ·  Evette van Niekerk, M Dietetics (1)  ·  Fahri Ovali (1)  ·  GHada A. Saleh, MRCPCH (1)  ·  Gamze Demirel, MD (1)  ·  Jon E. Tyson, MD MPH (1)  ·  Josef Neu, MD (1)  ·  Juan M Lozano, MD, Msc (1)  ·  Lu-Ann Papile, MD (1)

Results publications

PMID 11430325, PMID 12622582, PMID 16647401, PMID 16769377, PMID 17188612, PMID 17307535, PMID 17636753, PMID 18245398, PMID 19117897, PMID 21727276, PMID 23071204, PMID 24309022, PMID 24919691, PMID 25861285, PMID 28710882, PMID 33006765, PMID 33058137, PMID 33704071, PMID 34815288, PMID 36143388, PMID 37493095, PMID 38545091, PMID 38556499, PMID 40348496

NIH funding

K01DK075478 (1), K08HD052885 (1), M01RR000070 (1), M01RR000997 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD021397 (1), U10HD027851 (1), U10HD027880 (1), U10HD027881 (1), U10HD027904 (1), U10HD034216 (1)